Press Releases

MENLO PARK, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Today, Robinhood Ventures Fund II (RVII) announced the pricing of its initial public offering of 8,000,000 common shares of beneficial interest at an initial public offering price of $25.00 per share. This brings the total size of the Fund to $225.5 million, or up to $255.5 million if the underwriter’s option to purchase additional common shares is exercised in full. The total fund size is calculated before deducting the sales load and offering expenses. The shares are expected to begin trading on the New York Stock Exchange (NYSE) on Aug. 13, 2026 under the symbol RVII, and the offering is expected to close on Aug. 14, 2026, subject

San Antonio, Texas--(Newsfile Corp. - August 13, 2026) - HIVE Digital Technologies Ltd. (TSX:HIVE) (NASDAQ:HIVE) (BVC: HIVECO) (the "Company" or "HIVE"), today announced it will release its financial results for fiscal Q1 2027 on Friday, August 14, 2026, after market close, followed by an earnings conference call and webcast on Monday, August 17, 2026, at 8:00 AM EST.Conference Call InformationTo participate in this event, please log on or dial in approximately 5 minutes before the call.Date: August 17, 2026Time: 8:00 AM EST Webcast: Registration link here Dial-in: Provided after registrationA copy of the earnings release and a replay of the call will be available on the Company's investor r

Company announcement – No. 39 / 2026 Zealand Pharma Announces Financial Results for the First Half of 2026 A landmark first half defined by key milestones delivered for leading obesity assets, and a continued momentum building across all fronts of our Metabolic Frontier 2030 strategy. Announced decision to advance petrelintide into Phase 3 trials in H2 2026 following positive Phase 2 results, demonstrating double-digit weight loss with a tolerability profile largely comparable to placebo, supporting its potential to redefine the weight management experience for people living with obesity or overweight.Boehringer Ingelheim presented positive results from the SYNCHRONIZETM-1 and SYNCHRONIZE

Launch marks first commercial availability of Joenja® (leniolisib) for children aged 4 to 11 worldwide OrphanPacific, Inc. serves as Marketing Authorization holder and is responsible for supply and distribution in Japan Leiden, the Netherlands, August 13, 2026: Pharming Group (NASDAQ:PHAR), today announced the commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with activated PI3K delta syndrome (APDS) aged 4 years and older, following its inclusion on the Japan National Health Insurance (NHI) drug price list. With this launch, Japan is now the first market where Joenja is commercially available for children aged 4 to 11. "This launch is an important milest

Total product sales of €64.0 million In-line with expectations; full-year guidance of €135 -150 million reaffirmed Solid cash position of €121.5 million as of end June 2026 Reflects disciplined cash management and proceeds from the recent reserved offering1 Restructuring program implemented with positive P&L and cash flow impacts expected in the second half of the year and beyond Regulatory decisions for Lyme disease vaccine candidate expected in the next twelve months2   Pfizer remains optimistic about obtaining registration for the vaccine candidate3 Lyon (France), August 13, 2026 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today reported its condensed consolid

Delek Logistics Partners, LP (NYSE:DKL) ("Delek Logistics") announced today the pricing of its underwritten public offering of 4,000,000 common units representing limited partner interests in Delek Logistics at $50.00 per unit. The offering is being made pursuant to an effective shelf registration statement previously filed with the Securities and Exchange Commission (the "SEC"). A preliminary prospectus supplement relating to the offering has also been filed with the SEC. Delek Logistics has granted the underwriters a 30-day option to purchase up to 600,000 additional common units. Delek Logistics intends to use the net proceeds from the offering (including any net proceeds from the underw

AbCellera Biologics Inc. (NASDAQ:ABCL) ("AbCellera") today announced the pricing of its oversubscribed underwritten public offering of 17,435,897 common shares at a price to the public of $9.75 per share and, in lieu of common shares to certain investors, pre-funded warrants to purchase up to 3,076,926 shares of its common shares at a price to the public of $9.74999 per pre-funded warrant, which represents the per share public offering price of each common share less the $0.00001 per share exercise price for each pre-funded warrant. The gross proceeds to AbCellera from the offering are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and e

PITTSBURGH, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ:DUOL), the world's leading mobile learning platform, announced today it has acquired Animade, a London-based animation and motion design studio recognized for its work in product storytelling, brand, interactive experiences, and character animation. The acquisition expands Duolingo's Design Studio, strengthening a capability that has become increasingly important to delivering engaging product experiences and accelerating innovation. "Great products aren't defined only by what they do, but by how they make people feel," said Mig Reyes, Head of Design at Duolingo. "Motion design has become a core part of how we help learn

ATHENS, Greece, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Reference is made to the key information relating to Q2 2026 dividend announced by Okeanis Eco Tankers Corp. ("OET" or the "Company") (NYSE:ECO) on August 4, 2026. The Company's common shares will be traded ex dividend USD 5.25 per common share on the Oslo Stock Exchange from today, August 13, 2026 and on the New York Stock Exchange from August 14, 2026. Contacts Company:Iraklis Sbarounis, CFOTel: +30 210 480 4200ir@okeanisecotankers.com Investor Relations / Media Contact:Nicolas Bornozis, PresidentCapital Link, Inc.230 Park Avenue, Suite 1540, New York, N.Y. 10169Tel: +1 (212) 661-7566okeanisecotankers@capitallink.com About OET OET is

Northern Trust (NASDAQ:NTRS) today announced that it has expanded its relationship with First Sentier Group, being appointed fund administrator for First Sentier Investors Global Growth Funds, a Singapore unit trust offering. Under the expanded mandate, Northern Trust will provide custody, fund accounting and transfer agency services for First Sentier Investors Global Growth Funds. The arrangement combines local Singapore transfer agency capabilities with Northern Trust’s global operating platform, supporting a consistent, scalable and resilient servicing framework for the Singapore unit trust offering while aligning with First Sentier Group’s broader operating model objectives and local

ISELIN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) ("Outlook Therapeutics"), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, today announced the pricing of an underwritten public offering of 55,555,556 shares of its common stock and accompanying warrants to purchase up to an aggregate of 55,555,556 shares of its common stock. The combined public offering price of each share of common stock and accompanying warrant to purchase one share is $0.99. The accompanying warrants have an exercise price of $1.10 per share, will become exercisabl

U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) with Priority Review for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); Prescription Drug User Fee Act (PDUFA) target action date of February 12, 2027Company presented additional positive secondary endpoint data from the Phase 3 DRAGON trial of tinlarebant at the American Society of Retina Specialists (ASRS) Annual Meeting with quantitative autofluorescence (qAF) showing a marked divergence between treatment groupsConference call and webcast on Thursday, August 13, 2026, at 4:30 p.m. ET SAN DIEGO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company

SALEM, Ore., Aug. 12, 2026 /PRNewswire/ -- Willamette Valley Vineyards, Inc. (NASDAQ:WVVI) (the "Company"), a leading Oregon producer of Pinot Noir, generated a loss per common share after preferred dividends of $0.40 and $0.09 for the three months ended June 30, 2026 and 2025 respectively, an increase of $0.31, for the three month period ended June 30, 2026 over the same three month period in the prior year.  Sales revenue for the three months ended June 30, 2026 and 2025 were $10,036,275 and $10,195,763, respectively, a decrease of $159,488, or 1.6%, in the current year period over the prior year period. This decrease was cau

PHOENIX, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ:GWRS), a pure-play water resource management company, reported results for the three and six months ended June 30, 2026. Unless otherwise noted, all comparisons are to the corresponding period in the prior year. The company will hold a conference call at 1:00 p.m. Eastern time tomorrow to discuss the results (see dial-in information below). Q2 2026 Financial Highlights Total revenue increased $3.5 million or 24.8% year-over-year (YoY) to $17.8 million. The increase was primarily due to the recognition of $2.1 million in unregulated revenue related to infrastructure coordination and financing agreements (ICFA)

Approval of the Private Placement Proposal will help the Company further its EAI Robotics goals in 2026, meet its contractual obligations, support future capital raising efforts, and enable mutual reinforcement between its core EAI business and the digital asset ecosystem. The Company is scheduled to report its second quarter 2026 financial results after market close on Thursday, August 13, 2026, and will hold an earnings call at 4:00 p.m. where additional business updates will be communicated. Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future," "FF," or the "Company"), a California-based global Embodied AI (EAI) ecosystem company, today announced the results of

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Therapeutics, Inc. (NASDAQ:CGEM) today announced that the REZILIENT3 trial, a global Phase 3 clinical trial evaluating the combination of zipalertinib and platinum-based chemotherapy compared with chemotherapy alone in the first-line treatment of adult patients with previously untreated, locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations, met its primary endpoint of progression-free survival (PFS) at a planned interim analysis. In this analysis, the study demonstrated a statistically significant and clinically meaningful

Suzano, the world’s largest pulp producer, announces its results for the second quarter of 2026 (2Q26), reporting higher prices, stronger volumes and improvements in Adjusted EBITDA and operating cash generation compared to the previous quarter. The quarterly results reflect the competitiveness and resilience of Suzano’s operations in a quarter marked by foreign exchange headwinds and pressure on input costs driven by higher oil prices affecting the industry as a whole. Suzano sold 3.3 million tonnes of pulp and paper combined in 2Q26, comprising 2.9 million tonnes of pulp and 406 thousand tonnes of paper across the packaging, printing and writing, specialty and tissue segments. Net reven

Revenue of $1.9 million and positive gross profit despite higher power costs and challenging digital asset market conditionsGAAP net loss of $5.5 million; Net Cash Burn of approximately $61,000, an improvement of approximately 88% from the first quarter of 2026Cash and digital assets totaled approximately $57.9 million as of June 30, 2026 SALT LAKE CITY, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Datacentrex, Inc. ("Datacentrex" or the "Company") (NASDAQ:DTCX), a diversified technology-driven enterprise operating a digital asset mining business, today reported financial results for the second quarter ended June 30, 2026. "Second-quarter results reflected a challenging operating environment, parti

MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, announced the results of the August 2026 Index Review for the MSCI Equity Indexes. All changes will be implemented as of the close of August 31, 2026. Highlights include: MSCI Global Standard Indexes: Fifty-five securities will be added to and 92 securities will be deleted from the MSCI ACWI® Index. The three largest additions to the MSCI World Index measured by full company market capitalization will be SanDisk (USA), Carpenter Technology (USA) and ATI (USA). The three largest additions to the MSCI Emerging Markets Index measured by full company market capitali

Mobilewalla Holdco, Inc. ("Mobilewalla" or the "Company"), a leading provider of consumer data and vertical agentic AI solutions, and SPACSphere Acquisition Corp. (NASDAQ:SSAC) ("SPACSphere" or "SSAC"), a publicly traded special purpose acquisition company, today announced the public filing of a registration statement on Form S-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC"), containing a preliminary proxy statement and prospectus relating to their previously announced proposed business combination. A copy of the Registration Statement can be found at both the Securities and Exchange website at www.sec.gov and Mobilewalla’s website at www.mobilewall